-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster III

Symposia: Hodgkin Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Michele D. Stanchina, DO, MS1, Russ Kuker, MD2*, Sunwoo Han, PhD3*, Fei Yang, PhD2*, Mark K Polar, MD2*, Jillian Lorayne Lykon, PharmD4*, Tracy Crane, PhD, RDN5*, Melissa Lopez-Pentecost, PhD, RDN5*, Craig H. Moskowitz, MD1 and Juan Pablo Alderuccio, MD1

1Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL
2Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL
3Biostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
4Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
5Sylvester Comprehensive Cancer Center, Medical Oncology and Public Health, University of Miami, Miami, FL

Amira Marouf, MD, PhD1, Cedric Rossi, MD, PhD2,3, Tesla Murairi4*, Fanny Cherblanc, PhD5*, Loic Chartier6*, Hervé Ghesquieres, MD, PhD7* and Bénédicte Deau Fischer, MD8,9*

1INSERM U1163 Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, Institut IMAGINE, Université Paris Cité, PARIS, France
2CHU Dijon, DIJON, France
3INSERM 1231, Dijon, France
4Department of Biostatistics, Lymphoma Academic Research Organisation (LYSARC), Lyon, France
5Lymphoma Academic Research Organisation, Lyon, France
6Department of Biostatistics, Lymphoma Academic Research Organization (LYSARC), Lyon, France
7Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
8Department of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
9Groupe Hospitalier privé Ambroise Paré-Hartmann, Département Recherche Innovation, Neuilly Sur Seine, France

Gaurav Varma, MD, MSPH1,2, Maya C. Rosenberg, MD2*, Erica C. Agbadiba, BS3*, Austin H. Yeung, BS4*, Ayo S. Falade, MD, MBA5,6*, Marcus P. Watkins, PhD7*, Grace T. Baek8*, Herman van Besien, MD1*, Kelsey Baron, MD9, Meghana K. Subramanian, MD10*, Sara Prischak, BS11*, Joe D. Lukowski, MPH12*, Christopher D’Angelo, MD12*, Jakub Svoboda, MD11, Joanna M. Rhodes, MD10, Harsh R. Shah, DO9, Samuel Yamshon, MD1*, Ajay K. Gopal, MD13, Nancy L. Bartlett, MD14, Reid W. Merryman, MD5, Ranjana H. Advani, MD4, Sairah Ahmed, MD3 and Catherine S. Diefenbach, MD2

1Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY
2Perlmutter Cancer Center, NYU Langone Health, New York, NY
3Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
4Stanford Cancer Institute, Stanford University, Stanford, CA
5Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
6Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN
7Division of Oncology, Washington University School of Medicine, St. Louis, MO
8Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
9Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
10Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
11Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
12Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
13University of Washington, Seattle, WA
14Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Fjoralba Kristo1*, Flora Mazerolle2*, Thibaud Alin2*, Antoine Regnault2*, Justin Ferdinandus, MD3*, Karolin Behringer3*, Janina Jablonski3*, Peter Borchmann, MD3 and Ajibade Ashaye, MD, MS, MBA, MPH1

1Takeda Development Center Americas, Inc., Cambridge, MA
2Modus Outcomes, a THREAD company, Lyon, France
3German Hodgkin Study Group and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Christopher J. Forlenza, MD1, Opeyemi Jegede2*, Stephen M. Ansell, MD, PhD3, Christian Steidl, MD, PhD4, Yasodha Natkunam, MD, PhD5, David W. Scott, MBChB, PhD6, Neha Mehta-Shah, MD7, Jennifer E. Amengual, MD8, Peter D. Cole, MD9, Brad S. Kahl, MD10 and Catherine S. Diefenbach, MD11

1Memorial Sloan Kettering Cancer Center, New York, NY
2CIMAC-CIDC Network, Department of Data Science, Boston, MA
3Division of Hematology, Mayo Clinic, Rochester, MN
4Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
5Department of Pathology, Stanford University School of Medicine, Stanford, CA
6Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
7Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
8Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
9Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute, New Brunswick, NJ
10Department of Medicine, Washington University School of Medicine, St. Louis, MO
11Perlmutter Cancer Center at NYU Langone Health, New York, NY

Paul J. Bröckelmann, MD1*, Ina Bühnen, MSc1*, Josée M Zijlstra, MD, PhD2, Stephan Mathas, MD3*, Katrin S Roth, MD4*, Maria Garcia-Marquez, PhD5*, Christian Sillaber, MD6*, Julia Meissner, MD7*, Alexander Fossa, MD8*, Richard Greil, MD9, Karolin Trautmann-Grill10*, Johannes Rosenbrock, MD11*, Wouter Plattel, MD, PhD12*, Hans A Schlösser, MD13*, Carsten Kobe, MD4*, Michael Fuchs, MD14*, Peter Borchmann, MD1 and Christian Baues, MD15*

1University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
2Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
3Charité Berlin, Berlin, DEU
4Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
5Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany
6Medical University Vienna, Vienna, AUT
7Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
8Department of Oncology, Oslo University Hospital, Oslo, Norway
93rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
10University Hospital Carl Gustav Carus, Dresden, Germany
11Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
12Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
13Center for Molecular Medicine Cologne and Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
14Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
15Department of Radiation Oncology, University Hospital of Ruhr-Universität Bochum, Marien Hospital Herne, Herne, Germany

Alayna M. Santarosa, MPH1,2*, Nivetha Ganesan, MPH1*, Tiffany Chang, MS1*, Kelly Hannigan3*, Ellie Casper, MS, DPT2*, Gunjan L. Shah, MD4,5, Alexander P. Boardman, MD2*, Philip Caron, MD2, Kevin A. David, MD2*, Ahmet Dogan, MD, PhD1, Zachary D. Epstein-Peterson, MD2, Lorenzo Falchi, MD2, Paola Ghione, MD2, Paul A. Hamlin, MD2, Steven Horwitz, MD2, Andrew M. Intlekofer, MD, PhD2, William T. Johnson, DO6, Ariel Krivisky, RN7*, Anita Kumar, MD8, Jennifer Kimberly Lue, MD2, Efrat Luttwak, MD2, Ariela Noy, MD2, Colette Owens, MD2, Maria Lia Palomba, MD2, Gilles Salles, MD, PhD9, Heiko Schoder, MD1*, Raphael E. Steiner, MD2, Robert Stuver, MD2, Pallawi Torka, MD2, Santosha A. Vardhana, MD, PhD2, Joachim Yahalom, MD10, Andrew D. Zelenetz, MD, PhD2, Craig H. Moskowitz, MD11 and Alison Moskowitz, MD2

1Memorial Sloan Kettering Cancer Center, New York, NY
2Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY
4Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York
6Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Lymphoma Department, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
9Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Tine Kopp1*, Jonas Banefelt2*, Mathias Lilja2*, Susan Hall3*, Laura Hendrix3*, Sigrid DaVeiga3* and John Diaz-Decaro, PhD, MS4*

1Quantify Research, Copenhagen, Denmark
2Quantify Research, Stockholm, Sweden
3Moderna Therapeutics, Inc, Cambridge
4Moderna Therapeutics, Inc, Potomac, MD

Grace T. Baek1,2*, Gaurav Varma, MD, MSPH3,4, Samuel Yamshon, MD4*, Herman van Besien, MD4*, Nancy L. Bartlett, MD5, Marcus P. Watkins, PhD6*, Harsh R. Shah, DO7, Kelsey Baron, MD7, Reid W. Merryman, MD8, Ayo S Falade, MD, MBA9,10, Jakub Svoboda, MD11, Sara Prischak, BS11*, Christopher R D'Angelo, MD12, Joe D. Lukowski, MPH13*, Ranjana H. Advani, MD14, Austin H. Yeung, BS15*, Maya C. Rosenberg, MD3*, Jenna M. Voutsinas, MPH16*, Mengyang Di, MD, PhD17,18, Ryan C Lynch, MD17,18, Christina Poh, MD17,18, Vikram Raghunathan, MD17,18*, Mazyar Shadman, MD, MPH17,18, Stephen D. Smith, MD17,18, Brian G. Till, MD1,18, Chaitra S. Ujjani, MD17,18, Catherine S. Diefenbach, MD3 and Ajay K. Gopal, MD17,18

1Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
2Fred Hutchinson/University of Washington Cancer Consortium, Seattle, WA
3Perlmutter Cancer Center, NYU Langone Health, New York, NY
4Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY
5Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
6Division of Oncology, Washington University School of Medicine, St. Louis, MO
7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
8Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9Division of Hematology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN
10Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
11Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
12Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
13Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
14Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
15Stanford Cancer Institute, Stanford University, Stanford, CA
16Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
17Fred Hutchinson Cancer Center, Seattle, WA
18Division of Hematology and Oncology, University of Washington, Seattle, WA

Karla Machlab, MD1, Vivian Aghanya2*, Lee Mozessohn, MD3, Michael Crump, MD4*, Danielle Rodin, MD, MPH5*, Ning Liu, PhD6* and Anca Prica, MD7

1University of Toronto, Toronto, ON, Canada
2Institute for Clinical Evaluative Sciences, Toronto, Canada
3Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
5Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
6ICES, Toronto, ON, Canada
7Divison of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Tatyana Feldman, MD1, Enrica Marchi, MD, PhD2, Stephen D. Smith, MD3, Adam J. Olszewski, MD4, Auris O Huen, MD, PharmD5*, Zachary D. Epstein-Peterson, MD6, Don A. Stevens, MD7, Alexander N. Starodub, MD8*, Eric J. Feldman, MD9*, Cristina P Rodriguez, MD10*, John C. Reneau, MD, PhD11, Jonathan E. Brammer11, Ahmad H. Mattour, MD12, Lauren C. Pinter-Brown, MD, FACP13*, Rachelle Perea14*, Patrick Henrick, BS15*, Joyoti Dey, PhD, MPH15*, Alyssa Fasciano, PhD15*, Rahul Karnik, PhD15*, Sagar Agarwal, PhD15*, Ashwin Gollerkeri, MD15*, Jared Gollob, MD15*, Aditi Shastri, MD16 and Stefan K. Barta, MD17

1John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
2Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA
3Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
4Brown University, Providence, RI
5Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Norton Cancer Institute, Louisville, KY
8The Christ Hospital Cancer Center, Cincinnati, OH
9Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
10University of Washington, Division of Medical Oncology, Seattle, WA
11The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
12Hematology and Oncology; Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI
13University of California Irvine, Irvine, CA
14Kymera Therapeutics, Boston, MA
15Kymera Therapeutics, Watertown, MA
16Montefiore Medical Center, Bronx, NY
17Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Alexandra Dreyfuss, MD, MSTR1*, Nivetha Ganesan, MPH2*, Alvaro J Alencar, MD3, Alexander P. Boardman, MD4*, Philip Caron, MD4, Tiffany Chang, MS2*, Theresa Davey, MMSc, PA-C2*, Kevin A. David, MD4*, Ahmet Dogan, MD, PhD2, Zachary D. Epstein-Peterson, MD4, Lorenzo Falchi, MD2, Beatrice Fregonese, MPH1*, Paola Ghione, MD, MSEpi2, Paul A. Hamlin, MD4, Steven Horwitz, MD4, Brandon S. Imber, MD, MA1, Andrew M. Intlekofer, MD, PhD4, Derek Isrow, MD, PhD5*, Erel Joffe, MD2*, William T. Johnson, DO6, Anita Kumar, MD7, Michael Lariviere, MD8*, Jennifer Kimberly Lue, MD4, Efrat Luttwak, MD4, Michael McNicholas8*, Zachary Moore, MD, PhD1*, Brittney Munayirji2*, Ariela Noy, MD9, Colette Owens, MD4, Maria Lia Palomba, MD4, Jaldhi Patel8*, John P Plastaras, MD, PhD8*, Alayna M. Santarosa, MPH2*, Heiko Schoder, MD2*, Gunjan L. Shah, MD10, Raphael E. Steiner, MD2, Robert Stuver, MD4, Jakub Svoboda, MD8, Pallawi Torka, MD2, Santosha A. Vardhana, MD, PhD4, Andrew D. Zelenetz, MD, PhD4, Gilles Salles, MD, PhD11, Joachim Yahalom, MD1, Craig H. Moskowitz, MD12 and Alison Moskowitz, MD4

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
4Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Sylvester Comprehensive Cancer Center, Department of Radiation Oncology, University of Miami, Miller School of Medicine, Miami
6Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
8School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
9Memorial Sloan-Kettering Cancer Ctr., New York, NY
10Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
12Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL

Jasmine Zain, MD1, Jeffrey Wong, MD2*, Steven Horwitz, MD3, Neeta Pandit-Taskar, MD4*, Anas Al-Janadi, MD5*, Brandon Mancini, MD6*, Rizwan Khawaja, MD7*, Christina Y. Lee, MD8, Adrian Howansky, PhD8*, Darla Liles, MD9, Aidan Burke, MD9*, Brian H. Santich, PhD10*, Danny Klindt Fonnes11*, Vignesh Rajah, MD12*, Norman LaFrance, MD10* and Charlotte A. Russell, MD11

1City of Hope, Duarte, CA
2Radiation Oncology, City of Hope National Medical Center, Duarte, CA
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Corewell Health, Grand Rapids, MI
6BAMF Health, Grand Rapids, MI
7HonorHealth, Scottsdale, AZ
8Stony Brook Cancer Center, Stony Brook, NY
9East Carolina University Health, Greenville, NC
10Science and Translational Medicine, Y-mAbs Therapeutics Inc, New York, NY
11Clinical Development, Y-mAbs Therapeutics A/S, Hørsholm, Denmark
12Clinical Development, Y-mAbs Therapeutics, New York, NY

Raphael Steiner, MD1*, Allison M. Bock, MD2, Alex F. Herrera, MD3, Omer Zulfa4*, Marc Hoffmann, MD5, Sami Ibrahimi, MD6, Natalie Galanina, MD7*, Hun Ju Lee, MD8, Michael Green, PhD8, Ruitao Lin, PhD9*, Chelsea C. Pinnix, MD, PhD10, Alison Moskowitz, MD1, Joachim Yahalom, MD11 and Dai Chihara, MD, PhD8

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
3City of Hope, Duarte, CA
4University of Cinncinati, Cincinatti, OH
5The University of Kansas Medical Center, Kansas City, KS
6University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK
7UPMC Hillman Cancer Center, Pittsburgh, PA
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Sanjal H. Desai, MBBS1, Qing Cao, MSc2*, Marie Hu, MD3, Joseph E. Maakaron, MD4 and Veronika Bachanova, MD, PhD5

1University of Minnesota, Saint Paul, MN
2Biostatistics and Informatics, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN
3Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
4Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
5Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

*signifies non-member of ASH